Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89,506,929
-
Total 13F shares
-
19,945,609
-
Share change
-
-192,934
-
Total reported value
-
$113,888,639
-
Put/Call ratio
-
0%
-
Price per share
-
$5.71
-
Number of holders
-
29
-
Value change
-
-$1,092,679
-
Number of buys
-
6
-
Number of sells
-
14
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Stock (MIST) as of Q3 2021
As of 30 Sep 2021 Milestone Pharmaceuticals Inc. - Common Stock (MIST) had 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 19,945,609 shares of stock of the company.
Largest 10 holders included RTW INVESTMENTS, LP, ORBIMED ADVISORS LLC, BOXER CAPITAL, LLC, Novo Holdings A/S, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, and MILLENNIUM MANAGEMENT LLC.
This table shows 26 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.